Last edited by Mok
Friday, May 8, 2020 | History

3 edition of Advances in research on cholera and related diarrheas found in the catalog.

Advances in research on cholera and related diarrheas

Advances in research on cholera and related diarrheas

  • 278 Want to read
  • 16 Currently reading

Published by M. Nijhoff, Distributor for the U.S. and Canada, Kluwer Boston in Boston, Hingham, MA .
Written in English

    Subjects:
  • Cholera -- Immunological aspects.,
  • Cholera -- Vaccination.,
  • Diarrhea -- Immunological aspects.,
  • Cholera.,
  • Diarrhea.

  • Edition Notes

    Includes bibliographies and indexes.

    Statementedited by S. Kuwahara, N.F. Pierce.
    SeriesNew perspectives in clinical microbiology ;, 6
    ContributionsKuwahara, Shōgo, 1921-, Pierce, N. F.
    Classifications
    LC ClassificationsRC126 .A2 1983
    The Physical Object
    Paginationviii, 306 p. :
    Number of Pages306
    ID Numbers
    Open LibraryOL3171043M
    ISBN 10089838592X
    LC Control Number83013220

    Humanity, like the armies in the field, advances at the speed of the slowest. Those of us who make the rules have the greatest obligation to abide by them. I don't believe in God but I am afraid of him. It's better to arrive in time than to be invited. Unfaithful but not disloyal. Love, no matter what else it . The Management of Acute Diarrhea in Children: Oral Rehydration, Maintenance, and Nutritional Therapy M.D. Merck Research Laboratories West Point, Pennsylvania Nalin DR. Sucrose in oral therapy for cholera and related diarrheas. Lancet ; Nalin DR, Levine MM, Mata L, et al. Comparison of sucrose with glucose in oral.

    Statements about the incubation period of cholera are often imprecise, unsourced, or based on limited information. Statements of the incubation period such as “a few hours to a few days” or “five days” are common, and it is often unclear if they refer to the mean incubation period, its maximum, the full range or some other by: Cholera is an acute, diarrheal illness caused by infection of the intestine with the bacterium Vibrio cholerae. An estimated million cases and over , deaths occur each year around the world. The infection is often mild or without symptoms, but can sometimes be severe. Approximately one in 10 (5 to 10 percent) infected persons will have severe disease characterized by profuse watery.

      Advance In Cholera Bacteria Points To New Treatment And Vaccine Date: December 8, Source: Dartmouth Medical School Summary: Opening a new .   Data on the cholera patients admitted monthly to the ICDDR,B, hospital in Dhaka (Bangladesh) from through have been studied and analysed. Although Vibrio cholerae variant El Tor did not enter Bangladesh until , it has completely displaced classical cholera since There have also been changes in seasonality, which are by:


Share this book
You might also like
Arrangements and conditions for the award of the national certificates and diplomas of the Institution of Electrical Engineers in conjunction with the Board of Education.

Arrangements and conditions for the award of the national certificates and diplomas of the Institution of Electrical Engineers in conjunction with the Board of Education.

family meets the depression

family meets the depression

Algebra

Algebra

The 2000 Import and Export Market for Watches and Clocks in Asia (World Trade Report)

The 2000 Import and Export Market for Watches and Clocks in Asia (World Trade Report)

Guide to Leamington, Warwick etc..

Guide to Leamington, Warwick etc..

plan for water & sewer, 1973-1985

plan for water & sewer, 1973-1985

Infringements of copyrights.

Infringements of copyrights.

Lithofacies and their interpretation

Lithofacies and their interpretation

court of Versailles

court of Versailles

Language planning in Ireland

Language planning in Ireland

A not-so-dismal science

A not-so-dismal science

Mediating medical negligence claims

Mediating medical negligence claims

Fisheries management

Fisheries management

JOSEPH C. NIEMIEC, APPELLANT, V. TOGO D. WEST, JR., SECRETARY OF VETERANS AFFAIRS, APPELLEE... NO. 96-920... UNITED STATES COURT OF APPEALS

JOSEPH C. NIEMIEC, APPELLANT, V. TOGO D. WEST, JR., SECRETARY OF VETERANS AFFAIRS, APPELLEE... NO. 96-920... UNITED STATES COURT OF APPEALS

Jerome J. Day collection

Jerome J. Day collection

Advances in research on cholera and related diarrheas Download PDF EPUB FB2

The purpose of the Program was to promote cooperative biomedical research between the two countries, especially on health problems of recognized impor­ tance in Asia. Cholera was designated as one topic of mutual interest. Panels of scientists from each country were formed, and these met to select priority areas for : Springer Netherlands.

The purpose of the Program was to promote cooperative biomedical research between the two countries, especially on health problems of recognized impor­ tance in Asia.

Cholera was designated as one topic of mutual interest. Panels of scientists from each country were formed, and these met to select priority areas for : Paperback. The purpose of the Program was to promote cooperative biomedical research between the two countries, especially on health problems of recognized impor­ tance in Asia.

Cholera was designated as one topic of mutual interest. Panels of scientists from each country were formed, and these met to select priority areas for research.

COVID Resources. Reliable information about the coronavirus (COVID) is available from the World Health Organization (current situation, international travel).Numerous and frequently-updated resource results are available from this ’s WebJunction has pulled together information and resources to assist library staff as they consider how to handle coronavirus.

Advances in Research on Cholera and Related Diarrheas. [S Kuwahara; N F Pierce] -- The United States-Japan Cooperative Medical Science Program was initiated in by joint agreement between the President of the United States and the Prime Minister of Japan.

The seventh pandemic of cholera began in the early s and provided a stimulus for increased research on the pathogenesis of secretory diarrheal diseases caused by infectious microorganisms.

Cholera enterotoxin, the protein toxin of Vibrio cholerae that acts on the intestinal mucosa to produce the diarrhea of cholera, was purified to homogeneity in (1).Cited by: 1. The authors have already reported the endoscopic 1), microscopic 2) and electron microscopic findings 3) of the small intestine in human cholera.

In order to investigate the diarrheal mechanism further, endoscopy and simultaneous biopsy of the small intestine were done in patients with enterotoxicogenic Escherichia coli (ETEC) or Non-O Group 1 Vibrio cholerae or Nonagglutinating (NAG) vibrio : Tetsuo Morishita, Rafiqul Islam, Pradip K.

Bardhan, Yoshio Munakata, Toshifumi Hibi, Hitoshi Asakura. Advances in Research on Cholera and Related Diarrheas Oral Immunization for Cholera: Mucosal Antitoxic Immunity is Important and can Probably be Safely Achieved AuthorsAuthor: Nathaniel F.

Pierce, William C. Cray, John B. Sacci. Advances in Research on Cholera and Related Diarrheas, Vol. 3 (S. Kuwahara, and N.F. Pierce) (p. Martinus Nijhoff, The Hague.

FINKELSTEIN, R.A. (), Selection and characteristics of a Vibrio cholerae mutant lacking the A (ADP-ribosylating) portion of the cholera by: Diarrheal diseases have assumed an endemic and epidemic profile in the developing world as attested by the recent upsurge in the epidemics of (a) cholera in Angola and Cameroon, (b) dysentery in Sudan, Central African Republic, Bolivia, Paraguay, and (c) typhoid fever in the Democratic Republic of Congo and all these regions where diarrheal-related deaths have become quite frequent Cited by: Recent advances and new perspectives in targeting CFTR for therapy of cystic fibrosis and enterotoxin-induced secretory diarrheas Weiqiang Zhang, 1 Naoaki Fujii, 2 and Anjaparavanda P Naren 1, * 1 Department of Physiology, University of Tennessee Health Science Center, Union Avenue, Nash research building, Memphis, TNUSACited by: Abstract.

We have previously reported that two to five weeks old germ-free piglets developed cholera-like watery diarrhea consistently after orogastric inoculation with cholera toxin or Vibrio cholerae Inaba B.

1) Because Inaba B is an extraordinarily hypertoxigenic strain of Vibrio cholerae, we have further evaluated the germ-free piglet model by using strains with lower toxigenicity as Cited by: 1.

A research conducted in studying the correlation between climate variability and cholera prevalence Advances in Research on Cholera and Related Diarrhoeas, KTK Scientific Publishers, Tokyo, Japan (), pp. Cholera and Related Diarrheas, Karger Publishers (), pp.

Google : Md. Sirajul Islam, Md. Hassan-uz-Zaman, Md. Shafiqul Islam, John David Clemens, Niyaz Ahmed. Although the typhoid-cholera hybrid vaccine did not provide significant potection against experimental cholera, the study demonstrated the importance of antibody to V.

cholerae O antigen in ameliorating clinical illness and illustrated the use of an S. typhi carrier vaccine strain expressing a foreign antigen. 66 Cholera Vaccines SUMMARY The currently licensed parenteral cholera vaccine has not been a useful public health tool in the control of cholera.

Recent research has considerably increased our understanding of how cholera is transmitted, the mechanisms by which V. cholera O1 produces disease, and the functioning of the local intestinal immune response by which individuals can be protected from infection.

One result of these advances has been the development of experimental cholera. Effects of DNase production, plasmid size, and restriction barriers on transformation of Vibrio cholerae by electroporation and osmotic Advances in Research on Cholera and Related Diarrheas.

KTK Scientific Publishers, Tokyo. in press. It furthers the University's objective of excellence in research, scholarship, and education by Cited by: Cholera vaccines and antibiotics. Cholera vaccines have been used for > years with generally limited efficacy.

However, recent advances in the understanding of V. cholerae virulence and immunogenicity have led to a new generation of oral vaccines that have proved promising in clinical field studies. The currently available vaccines are based on either killed whole-cell bacteria including Cited by: Author(s): Kuwahara,Shōgo,; Pierce,N F(Nathaniel F.); Joint Conference on Cholera,(18th: Kurashiki-shi, Japan) Title(s): Advances in research on cholera and related diarrheas: proceedings of the 18th Joint Conference on Cholera/ edited by S.

Kuwahara, N.F. Pierce. Epidemiological features of epidemic cholera (El Tor) in Zimbabwe M. Bradley. 1 Communicable Diseases Research Unit, Blair Research Laboratory, Box CYHarare, Zimbabwe. Search for other works by this author on: Cholera and Related Diarrheas.

43rd Nobel Symposium, Stockholm Cited by:   Abstract. An improved fluorescent monoclonal antibody staining kit, Cholera DFA, for direct detection and enumeration of Vibrio cholerae O1 has been developed, employing a highly specific anti-A antigen monoclonal antibody, COLTA, labeled with fluorescein isothiocyanate (FITC).

An optimized quantity of anti-photobleaching agent is used in a glycerol mounting medium to retard the rapid fading Cited by:. Description: viii, p.: ill.

Language: English ISBN:X LCCN: MeSH: Cholera*; Diarrhea* Publication Type(s): Congresses Notes: "This volume records the findings presented at the Annual Joint Conference on Cholera held in Baltimore in "--P. [4] of cover. Conference held Oct.Cholera has attracted both global and public health attention due to its mode of transmission and severity.

For instance, cholera has become one of the most researched communicable diseases all.Cholera is an acute, watery diarrhoeal disease caused by Vibrio cholerae of the O1 or O serogroups. In the past two centuries, cholera has emerged and spread from the Ganges Delta six times and from Indonesia once to cause global pandemics.

Rational approaches to the case management of cholera with oral and intravenous rehydration therapy have reduced the case fatality of cholera from more.